Evercore Stock Price, News & Analysis

Evercore (NYSE: EVR) announces its 7th annual HealthCONx Conference to be held at the Loews Coral Gables Hotel in Florida, December 3-5, 2024. The invite-only event will feature over 600 industry experts and leaders from more than 225 healthcare companies. The conference will cover major healthcare verticals including Biotechnology, Pharma, Healthcare Distribution, Services & Technology, Life Science Tools & Diagnostics, and Healthcare Facilities & Managed Care. Attendees will participate in panels, fireside chats, investor meetings, and company-hosted dinners.

Evercore ISI has maintained its position as the #1 firm in U.S. Equity Research for the third consecutive year in Extel's All-America Equity Research survey. The firm's analysts secured 47 Top 3 or Runner Up positions, including 17 No. 1 rankings, up from 15 in 2023. Notable achievements include Ed Hyman's 44th consecutive year as No. 1 in Economics, and first-time No. 1 rankings for Elizabeth Anderson, Mark Mahaney, and Oscar Sloterbeck in their respective sectors. The 2024 survey reflects opinions from over 4,300 investment professionals across 1,600+ asset management firms and institutions.

Evercore (NYSE: EVR) has announced the appointment of Katrina Niehaus as Senior Managing Director to lead the firm's structured finance effort in New York. Niehaus brings over 20 years of experience, previously serving as managing director at Goldman Sachs where she led corporate structured finance. In her new role, she will focus on providing creative capital solutions through private ABS and asset finance. Niehaus holds a B.S. in economics from Wharton School and a master's from Columbia University.

Evercore (NYSE: EVR) reported strong Q3 2024 results with net revenues of $734.2 million on a U.S. GAAP basis, up 29% year-over-year. Operating income increased 59% to $122.0 million, with operating margins expanding to 16.6%. Advisory fees grew 27% to $593 million, while underwriting fees rose 43% to $44.1 million. The company maintained a quarterly dividend of $0.80 per share and returned $528.8 million to shareholders through dividends and share repurchases in the first nine months of 2024. Notable achievements include leading several major transactions and expanding their team with new senior managing directors.

Evercore (NYSE: EVR) has announced it will release its third quarter 2024 financial results on Wednesday, October 23, 2024 at 6:45 a.m. Eastern Time. The company will host a conference call at 8:00 a.m. Eastern Time the same day, featuring Chairman and CEO John S. Weinberg and CFO Tim LaLonde reviewing the firm's Q3 2024 results.

Investors and analysts can participate in the live conference call by dialing (800) 225-9448 (toll-free domestic) or (203) 518-9708 (international) with the passcode EVRQ324. A live audio webcast will be available on Evercore's website and archived for 30 days. The call is expected to last approximately one hour and will include a question and answer session.

Evercore (NYSE: EVR), the Digital Therapeutics Alliance (DTA), and HLTH are set to co-host a program on digital health and digital therapeutics at HLTH 2024 in Las Vegas, October 20-23. The event, titled 'Tech Meets Therapy: Evaluating the Digital Health Landscape', will take place on October 21 from 8-9 a.m. PST at the Venetian Expo Center.

The program will feature two panels of industry executives discussing the current investment environment in digital health and opportunities for strategic partnerships. This marks Evercore's sixth consecutive year hosting at HLTH and third year collaborating with DTA.

Elizabeth Anderson, Evercore ISI's Healthcare Technology & Distribution analyst, emphasized the importance of exploring sector trends related to investment outlooks and partnership opportunities. The event aims to provide attendees with expert insights on navigating the rapidly evolving digital therapeutics landscape.

Evercore (NYSE: EVR) has announced that Adam Frisch has joined Evercore ISI as a senior managing director to lead research coverage of the financial technology and IT services sectors. Frisch brings over 25 years of experience, including roles as a top-ranked research analyst, private company executive, and investment banker. He was previously the CEO of Buy It Mobility and spent 14 years as a research analyst at UBS and Morgan Stanley.

Frisch has been recognized as a No. 1 or No. 2 ranked analyst for five consecutive years in Institutional Investor's All-America Research poll. His addition to Evercore ISI is expected to strengthen the company's financials and technology research franchises, benefiting clients with his extensive knowledge and industry network.

Evercore (NYSE: EVR) has announced significant additions to its Paris office, strengthening its presence in the French market. Andrea Bozzi and Charles Andrez have joined as senior managing directors in the strategic advisory practice, while Charles-Henri Filippi has been appointed chairman of Evercore France. These appointments mark a major step in Evercore's expansion of its Investment Banking business in France.

Mr. Bozzi, with over 20 years at Lazard, will focus on advising leading corporates across Europe. Mr. Andrez, previously with Lazard, will develop Evercore's financial sponsors business. Mr. Filippi, a highly respected banker in France, joins from Lazard where he was co-chairman of Lazard Frères SAS.

The Paris office now has over 20 employees and is expected to continue growing. Evercore's EMEA presence includes offices in London, Paris, Frankfurt, Madrid, Tel Aviv, and Dubai, reflecting its commitment to serving corporate and financial sponsor clients across strategic advisory and private capital advisory services.

Evercore (NYSE: EVR) reported its Q2 2024 results with record net revenues of $689.2 million (U.S. GAAP) and $695.3 million (Adjusted), up 38% YoY. Operating income surged by 88% to $108.2 million (U.S. GAAP) and by 80% to $114.3 million (Adjusted). Net income attributable to Evercore doubled to $73.8 million. Diluted EPS soared to $1.81, reflecting significant profitability improvements.

Year-to-date, the company advised on major deals including GE's $36 billion spin-off, Synopsys' $35 billion acquisition of Ansys, and ConocoPhillips' $22.5 billion acquisition of Marathon Oil. Evercore's compensation ratio improved slightly to 66.6%, while its non-compensation costs rose by 18%.

Evercore announced a quarterly dividend of $0.80 per share. The firm returned $395.6 million to shareholders through dividends and share repurchases. The effective tax rate also decreased, contributing to the improved net income.